Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.
Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy, CEO of mTuitive.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice
Webinar presenters Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
April 2016—Myriad Genetics announced a strategic research collaboration with Tesaro and Merck (known as MSD outside the U.S. and Canada) to help identify potential responders to an investigational combination drug therapy using Tesaro’s PARP inhibitor (niraparib) plus Keytruda (pembrolizumab), Merck’s anti-PD-1 therapy.
April 2016—Illumina has acquired Conexio Genomics, based in Fremantle, Western Australia.
April 2016—Boekel Scientific introduced its Heat Cool Thermal Mixer II, which features a large intuitive touchscreen, interchangeable auto-recognized blocks to fit most laboratory consumables, multiple modes for increased process performance, and a large and accurate temperature and mixing range.
April 2016—Streck’s A1c-Cellular is now assayed for the Ortho-Clinical Diagnostics Vitros 4600. A1c-Cellular is an HbA1c control with intact red blood cells and tests the entire HbA1c procedure, including the lysing of the red blood cell.
April 2016—Leica Biosystems and Advanced Cell Diagnostics announced a comprehensive partnership to develop and commercialize tissue-based diagnostic tests based on ACD’s RNAscope in situ hybridization assays on Leica’s Bond clinical advanced staining instruments.
April 2016—LabStyle Innovations is preparing to launch its FDA-cleared Dario Blood Glucose Monitoring System in the United States.
April 2016—Arquer Diagnostics has signed an agreement with Euro Diagnostica for the manufacturing and supply of Arquer’s Mcm5-ELISA test for the diagnosis of bladder cancer.
April 2016—The BD FACSCelesta flow cytometer is designed to make multicolor flow cytometry more accessible and allow researchers to benefit from innovations in instrument and reagent technology.
April 2016—Siemens Healthcare Diagnostics plans to release a genetic assay designed to test for the presence of the Zika virus.
April 2016—Hardy Diagnostics announced the acquisition of Wichita Falls, Tex.-based GG&B Company, maker of automated microscope slide stainers for laboratory use.
